JP2021525275A5 - - Google Patents

Info

Publication number
JP2021525275A5
JP2021525275A5 JP2020567741A JP2020567741A JP2021525275A5 JP 2021525275 A5 JP2021525275 A5 JP 2021525275A5 JP 2020567741 A JP2020567741 A JP 2020567741A JP 2020567741 A JP2020567741 A JP 2020567741A JP 2021525275 A5 JP2021525275 A5 JP 2021525275A5
Authority
JP
Japan
Prior art keywords
solvent
ray diffraction
crystalline form
hydrazide
dimethylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020567741A
Other languages
English (en)
Japanese (ja)
Other versions
JP7883832B2 (ja
JP2021525275A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/018835 external-priority patent/WO2019164997A1/en
Publication of JP2021525275A publication Critical patent/JP2021525275A/ja
Publication of JP2021525275A5 publication Critical patent/JP2021525275A5/ja
Priority to JP2023218036A priority Critical patent/JP2024038090A/ja
Application granted granted Critical
Publication of JP7883832B2 publication Critical patent/JP7883832B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567741A 2018-02-21 2019-02-20 2,2,2-トリフルオロ酢酸1-(2,4-ジメチルフェニル)-2-[(3-メトキシフェニル)メチレン] ヒドラジド多形体およびその製造方法 Active JP7883832B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023218036A JP2024038090A (ja) 2018-02-21 2023-12-25 2,2,2-トリフルオロ酢酸1-(2,4-ジメチルフェニル)-2-[(3-メトキシフェニル)メチレン] ヒドラジド多形体およびその製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862633441P 2018-02-21 2018-02-21
US62/633,441 2018-02-21
PCT/US2019/018835 WO2019164997A1 (en) 2018-02-21 2019-02-20 2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl) methylene] hydrazide polymorphs and method of making the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023218036A Division JP2024038090A (ja) 2018-02-21 2023-12-25 2,2,2-トリフルオロ酢酸1-(2,4-ジメチルフェニル)-2-[(3-メトキシフェニル)メチレン] ヒドラジド多形体およびその製造方法

Publications (3)

Publication Number Publication Date
JP2021525275A JP2021525275A (ja) 2021-09-24
JP2021525275A5 true JP2021525275A5 (cg-RX-API-DMAC10.html) 2022-03-02
JP7883832B2 JP7883832B2 (ja) 2026-07-02

Family

ID=67686904

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020567741A Active JP7883832B2 (ja) 2018-02-21 2019-02-20 2,2,2-トリフルオロ酢酸1-(2,4-ジメチルフェニル)-2-[(3-メトキシフェニル)メチレン] ヒドラジド多形体およびその製造方法
JP2023218036A Pending JP2024038090A (ja) 2018-02-21 2023-12-25 2,2,2-トリフルオロ酢酸1-(2,4-ジメチルフェニル)-2-[(3-メトキシフェニル)メチレン] ヒドラジド多形体およびその製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023218036A Pending JP2024038090A (ja) 2018-02-21 2023-12-25 2,2,2-トリフルオロ酢酸1-(2,4-ジメチルフェニル)-2-[(3-メトキシフェニル)メチレン] ヒドラジド多形体およびその製造方法

Country Status (6)

Country Link
US (2) US10968167B2 (cg-RX-API-DMAC10.html)
EP (1) EP3755316A4 (cg-RX-API-DMAC10.html)
JP (2) JP7883832B2 (cg-RX-API-DMAC10.html)
CN (1) CN113747892A (cg-RX-API-DMAC10.html)
CA (1) CA3091782A1 (cg-RX-API-DMAC10.html)
WO (1) WO2019164997A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3755316A4 (en) * 2018-02-21 2022-05-25 Abrexa Pharmaceuticals, Inc. 2,2,2-TRIFLUOROACETIC ACID 1-(2,4-DIMETHYLPHENYL)-2-[(3-METHOXYPHENYL)-METHYLENE]HYDRAZIDE POLYMORPHS AND PROCESS FOR THEIR PREPARATION
WO2021222438A1 (en) * 2020-04-28 2021-11-04 Abrexa Pharmaceuticals, Inc. Compounds for prevention and treatment of post-intensive care cognitive dysfunction and cognitive dysfunction resulting from respiratory distress
JP2026518142A (ja) * 2023-05-26 2026-06-04 アブレキサ ファーマスーティカルズ,インコーポレイテッド 臓器保存および臓器移植に使用するための化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8779002B2 (en) 2007-10-15 2014-07-15 Salk Institute For Biological Studies Methods for treating a variety of diseases and conditions, and compounds useful therefor
CN105801496B (zh) * 2014-12-31 2018-03-13 广州喜鹊医药有限公司 三氟乙酰肼类化合物及其制备方法和在制药中的应用
WO2017015660A1 (en) * 2015-07-23 2017-01-26 Salk Institute For Biological Studies Prevention and treatment of aging and neurodegenerative diseases
EP3755316A4 (en) * 2018-02-21 2022-05-25 Abrexa Pharmaceuticals, Inc. 2,2,2-TRIFLUOROACETIC ACID 1-(2,4-DIMETHYLPHENYL)-2-[(3-METHOXYPHENYL)-METHYLENE]HYDRAZIDE POLYMORPHS AND PROCESS FOR THEIR PREPARATION

Similar Documents

Publication Publication Date Title
RU2577331C2 (ru) Кристаллическое основание миноциклина и способы его получения
JP7181896B2 (ja) オメカムティブメカルビルの合成
EP2896617B1 (de) Verfahren zur herstellung von substituierten (z)-alpha-fluoro-beta-amino-acrylaldehyden
KR102746929B1 (ko) 프로테인 카이네이즈에 대한 선택적 억제제의 합성에 유용한 중간체 및 이의 제조방법
JP3779155B2 (ja) クラリスロマイシン結晶型iiの製造方法
HRP20010514A2 (en) Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
EP3668857A1 (en) Processes for the preparation of niraparib and intermediates thereof
JP2610889B2 (ja) 新規架橋アデニン誘導体
JP2006513185A5 (cg-RX-API-DMAC10.html)
JP2023078126A (ja) 光学活性ジアザスピロ[4.5]デカン誘導体の分割
JP2021504458A (ja) サリチルアミド酢酸塩の製造方法
AU2010272364A1 (en) Process for preparing levosimendan and intermediates for use in the process
CN107868087B (zh) 一种制备吡咯并吲哚类衍生物的方法
JPH0478635B2 (cg-RX-API-DMAC10.html)
KR20100028543A (ko) 아로마타제 억제제의 제조 방법
CA1081694A (en) Rifamycin compounds
CN117603094B (zh) 一种氨基保护的2-氨基甲基烯酸衍生物的合成方法
KR20220044684A (ko) 살리실아민 아세테이트 제조방법
JP2001518106A (ja) 1,3−ジ置換2−ニトログアニジンの製造法
ES2761821T3 (es) Proceso para la preparación de intermedios útiles en la síntesis de eluxadolina
CN103819466B (zh) 一种药物活性化合物Cephalandole A的合成方法
KR101201203B1 (ko) 고순도 메티오졸린의 공업적 제조방법
EP1597263B1 (en) Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide a
RU2417995C1 (ru) Способ получения 3-(2-замещенных-1,3-оксазол-4-ил)пиридин-2(1н)-онов
WO2015162551A1 (en) Process for the preparation of apixaban